Ets-1 controls breast cancer cell balance between invasion and growth

International Journal of Cancer

Volumn 135, Issue 10, 2014, Pages 2317-2328

  Furlan, Alessandro ^a   Vercamer, Chantal ^a   Bouali, Fatima ^a   Damour, Isabelle ^a   Chotteau Lelievre, Anne ^a   Wernert, Nicolas ^b   Desbiens, Xavier ^a   Pourtier, Albin ^a  

^a INSTITUT DE BIOLOGIE DE LILLE   (France)

^b UNIVERSITY HOSPITAL BONN   (Germany)

Author keywords

3D; Breast cancer; Ets 1; Growth; Invasion; Matrix

Indexed keywords

KI 67 ANTIGEN; MATRIX METALLOPROTEINASE; SMALL INTERFERING RNA; TRANSCRIPTION FACTOR ETS 1; ETS1 PROTEIN, HUMAN;

ANIMAL CELL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; BREAST CANCER; BREAST CARCINOGENESIS; CANCER CELL; CANCER CELL CULTURE; CANCER GROWTH; CANCER PREVENTION; CELL ADHESION; CELL ASSAY; CELL DEATH; CELL DENSITY; CELL PROLIFERATION; CONTROLLED STUDY; DNA SEQUENCE; DOWN REGULATION; EPITHELIAL MESENCHYMAL TRANSITION; EXTRACELLULAR MATRIX; FEMALE; GENE DELETION; GENE OVEREXPRESSION; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; IN VITRO STUDY; IN VIVO STUDY; LUNG COLONIZATION ASSAY; METASTASIS; MOUSE; NONHUMAN; PROTEIN EXPRESSION; PROTEIN FUNCTION; THREE DIMENSIONAL IMAGING; TUMOR INVASION; 3D; ANIMAL; BAGG ALBINO MOUSE; BREAST TUMOR; CELL CYCLE; CELL MOTION; CULTURE TECHNIQUE; DRUG ANTAGONISM; DRUG SCREENING; ETS-1; GENETICS; GROWTH; INVASION; LUNG TUMOR; MATRIX; METABOLISM; NUDE MOUSE; PATHOLOGY; TUMOR CELL CULTURE; WESTERN BLOTTING;

3D; BREAST CANCER; ETS-1; GROWTH; INVASION; MATRIX;

ANIMALS; APOPTOSIS; BLOTTING, WESTERN; BREAST NEOPLASMS; CELL CULTURE TECHNIQUES; CELL CYCLE; CELL MOVEMENT; CELL PROLIFERATION; FEMALE; HUMANS; LUNG NEOPLASMS; MICE; MICE, INBRED BALB C; MICE, NUDE; NEOPLASM INVASIVENESS; PROTO-ONCOGENE PROTEIN C-ETS-1; RNA, SMALL INTERFERING; TUMOR CELLS, CULTURED; XENOGRAFT MODEL ANTITUMOR ASSAYS;

EID: 84908868602     PISSN: 00207136     EISSN: 10970215     Source Type: Journal    
DOI: 10.1002/ijc.28881     Document Type: Article

References (48)

1. Hu M, Yao J, Carroll DK, et al. Regulation of in situ to invasive breast carcinoma transition. Cancer Cell 2008;13:394-406.
2. Polyak K. Heterogeneity in breast cancer. J Clin Invest 2011;121:3786-8.
3. Maroulakou IG, Bowe DB. Expression and function of Ets transcription factors in mammalian development: a regulatory network. Oncogene 2000;19:6432-42.
4. Fafeur V, Tulasne D, Queva C, et al. The ETS1 transcription factor is expressed during epithelial-mesenchymal transitions in the chick embryo and is activated in scatter factor-stimulated MDCK epithelial cells. Cell Growth Differ 1997;8: 655-65.
5. Delannoy-Courdent A, Fauquette W, Dong-Le Bourhis XF, et al. Expression of c-ets-1 and uPA genes is associated with mammary epithelial cell tubulogenesis or neoplastic scattering. Int J Dev Biol 1996;40:1097-108.
6. Behrens P, Rothe M, Wellmann A, et al. The Ets-1 transcription factor is up-regulated together with MMP 1 and MMP 9 in the stroma of preinvasive breast cancer. J Pathol 2001;194:43-50.
7. Katayama S, Nakayama T, Ito M, et al. Expression of the ets-1 proto-oncogene in human breast carcinoma: differential expression with histological grading and growth pattern. Histol Histopathol 2005;20:119-26.
8. Span PN, Manders P, Heuvel JJ, et al. Expression of the transcription factor Ets-1 is an independent prognostic marker for relapse-free survival in breast cancer. Oncogene 2002;21:8506-9.
9. Furlan A, Vercamer C, Desbiens X, et al. Ets-1 triggers and orchestrates the malignant phenotype of mammary cancer cells within their matrix environment. J Cell Physiol 2008;215:782-93.
10. Delannoy-Courdent A, Mattot V, Fafeur V, et al. The expression of an Ets1 transcription factor lacking its activation domain decreases uPA proteolytic activity and cell motility, and impairs normal tubulogenesis and cancerous scattering in mammary epithelial cells. J Cell Sci 1998;111 (Part 11):1521-34.
11. Mattot V, Vercamer C, Soncin F, et al. Constitutive expression of the DNA-binding domain of Ets1 increases endothelial cell adhesion and stimulates their organization into capillary-like structures. Oncogene 2000;19:762-72.
12. Pourtier-Manzanedo A, Vercamer C, Van Belle E, et al. Expression of an Ets-1 dominant-negative mutant perturbs normal and tumor angiogenesis in a mouse ear model. Oncogene 2003;22:1795-806.
13. Castro F, Dirks WG, Fähnrich S, et al. High-throughput SNP-based authentication of human cell lines. Int J Cancer 2013;132:308-14.
14. Schneider CA, Rasband WS, Eliceiri KW. NIH Image to ImageJ: 25 years of image analysis. Nat Methods 2012;9:671-5.
15. .Dimri GP, Lee X, Basile G, et al. A biomarker that identifies senescent human cells in culture and in aging skin in vivo. Proc Natl Acad Sci USA 1995;92:9363-7.
16. Ohtani N, Zebedee Z, Huot TJ, et al. Opposing effects of Ets and Id proteins on p16INK4a expression during cellular senescence. Nature 2001;409:1067-70.
17. Chaffer CL, Weinberg RA. A perspective on cancer cell metastasis. Science 2011;331:1559-64.
18. Kalluri R, Weinberg RA. The basics of epithelial-mesenchymal transition. J Clin Invest 2009;119: 1420-8.
19. Tsai JH, Donaher JL, Murphy DA, et al. Spatiotemporal regulation of epithelial-mesenchymal transition is essential for squamous cell carcinoma metastasis. Cancer Cell 2012;22:725-36.
20. Fantozzi A, Christofori G. Mouse models of breast cancer metastasis. Breast Cancer Res 2006; 8:212.
21. Yamada KM, Cukierman E. Modeling tissue morphogenesis and cancer in 3D. Cell 2007;130:601-10.
22. Lee GY, Kenny PA, Lee EH, et al. Three-dimensional culture models of normal and malignant breast epithelial cells. Nat Methods 2007;4:359-65.
23. Hakkinen KM, Harunaga JS, Doyle AD, et al. Direct comparisons of the morphology, migration, cell adhesions, and actin cytoskeleton of fibroblasts in four different three-dimensional extracellular matrices. Tissue Eng A 2011; 17:713-24.
24. Fraley SI, Feng Y, Krishnamurthy R, et al. A distinctive role for focal adhesion proteins in threedimensional cell motility. Nat Cell Biol 2010;12: 598-604.
25. Wang W, Goswami S, Lapidus K, et al. Identification and testing of a gene expression signature of invasive carcinoma cells within primary mammary tumors. Cancer Res 2004;64:8585-94.
26. Giese A, Bjerkvig R, Berens ME, et al. Cost of migration: invasion of malignant gliomas and implications for treatment. J Clin Oncol 2003;21: 1624-36.
27. Hoek KS, Eichhoff OM, Schlegel NC, et al. In vivo switching of human melanoma cells between proliferative and invasive states. Cancer Res 2008; 68:650-6.
28. Schedin PJ, Eckel-Mahan KL, McDaniel SM, et al. ESX induces transformation and functional epithelial to mesenchymal transition in MCF-12A mammary epithelial cells. Oncogene 2004;23:1766-79.
29. Palmqvist R, Sellberg P, Oberg A, et al. Low tumour cell proliferation at the invasive margin is associated with a poor prognosis in Dukes' stage B colorectal cancers. Br J Cancer 1999;79:577-81.
30. Giese A. Glioma invasion - pattern of dissemination by mechanisms of invasion and surgical intervention, pattern of gene expression and its regulatory control by tumorsuppressor p53 and proto-oncogene ETS-1. Acta Neurochir Suppl 2003;88:153-62.
31. Nakayama T, Ito M, Ohtsuru A, et al. Expression of the ets-1 proto-oncogene in human colorectal carcinoma. Mod Pathol 2001;14:415-22.
32. Hahne JC, Okuducu AF, Sahin A, et al. The transcription factor ETS-1: its role in tumour development and strategies for its inhibition. Mini Rev Med Chem 2008;8:1095-105.
33. Palmer MB, Majumder P, Cooper JC, et al. Yin yang 1 regulates the expression of snail through a distal enhancer. Mol Cancer Res 2009;7:221-9.
34. Holterman CE, Franovic A, Payette J, et al. ETS-1 oncogenic activity mediated by transforming growth factor alpha. Cancer Res 2010;70:730-40.
35. Shaikhibrahim Z, Wernert N. ETS transcription factors and prostate cancer: the role of the family prototype ETS-1 (review). Int J Oncol 2012;40: 1748-54.
36. Polyak K, Weinberg RA. Transitions between epithelial and mesenchymal states: acquisition of malignant and stem cell traits. Nat Rev Cancer 2009;9:265-73.
37. Scheel C, Onder T, Karnoub A, et al. Adaptation versus selection: the origins of metastatic behavior. Cancer Res 2007;67:11476-9; discussion 9-80.
38. Gilles F, Raes MB, Stehelin D, et al. The c-ets-1 proto-oncogene is a new early-response gene differentially regulated by cytokines and growth factors in human fibroblasts. Exp Cell Res 1996;222: 370-8.
39. Oikawa M, Abe M, Kurosawa H, et al. Hypoxia induces transcription factor ETS-1 via the activity of hypoxia-inducible factor-1. Biochem Biophys Res Commun 2001;289:39-43.
40. Jiang J, Tang YL, Liang XH. EMT: a new vision of hypoxia promoting cancer progression. Cancer Biol Ther 2011;11:714-23.
41. Nguyen DX, Massague J. Genetic determinants of cancer metastasis. Nat Rev Genet 2007;8:341-52.
42. Petersen JM, Skalicky JJ, Donaldson LW, et al. Modulation of transcription factor Ets-1 DNA binding: DNA-induced unfolding of an alpha helix. Science 1995;269:1866-9.
43. Hollenhorst PC, McIntosh LP, Graves BJ. Genomic and biochemical insights into the specificity of ETS transcription factors. Annu Rev Biochem 2011;80:437-71.
44. Firlej V, Ladam F, Brysbaert G, et al. Reduced tumorigenesis in mouse mammary cancer cells following inhibition of Pea3- or Erm-dependent transcription. J Cell Sci 2008;121:3393-402.
45. Prescott JD, Poczobutt JM, Tentler JJ, et al. Mapping of ESE-1 subdomains required to initiate mammary epithelial cell transformation via a cytoplasmic mechanism. Mol Cancer 2011;10: 103.
46. Findlay VJ, Turner DP, Yordy JS, et al. Prostate-derived ETS factor regulates epithelial-tomesenchymal transition through both SLUGdependent and independent mechanisms. Genes Cancer 2011;2:120-9.
47. Laitem C, Leprivier G, Choul-Li S, et al. Ets-1 p27: a novel Ets-1 isoform with dominantnegative effects on the transcriptional properties and the subcellular localization of Ets-1 p51. Oncogene 2009;28:2087-99.
48. Choul-Li S, Leroy C, Leprivier G, et al. Caspase cleavage of Ets-1 p51 generates fragments with transcriptional dominant-negative function. Biochem J 2010;426:229-41.